Stake

Rate hikes may cause volatility, but it's all part of the cycle. Long-term investors are typically rewarded for staying diversified and patient.

Higher borrowing costs can put downward pressure on the market, particularly riskier growth stocks. Conversely, financials and consumer staple stocks tend to outperform.

Australia's central bank increased the cash rate by 25 basis points to 4.1%. It marks the second consecutive rate hike as the RBA looks to keep inflation pressures under control 👇

Yet $HIMS shares have jumped 50% this week after announcing a surprise partnership with Novo Nordisk $NVO, allowing it to sell Ozempic and Wegovy on its platform. Markets may move on narratives, but profits often emerge from constraints. Find the bottleneck, and the right trade might find you.

There’s one chokepoint retail investors particularly enjoy: the short squeeze. Telehealth company Hims & Hers $HIMS is one of the most shorted U.S.-listed firms, with short interest equal to 39% of its float.

What's happened this week? Oil had its wildest day in 20 years, $ORCL posted a major earnings beat, and the S&P 500 welcomed $VRT, $LITE, $COHR and $SATS. Trillions of dollars were wiped out and then added back in a violent Monday session on Wall Street. Crude futures surged 30% to US$119.48 as traders priced in signs of a looming global shortage.

An overnight mover was $ORCL Oracle shares are trading higher after the company reported better-than-expected Q3 financial results. You can check out the move on Stake 📈

Who are you picks for next week?

1-week performance 2 March to 6 March.

This March, we’re putting the biggest stocks on Wall St in a four-week, performance-driven showdown. Sixteen heavyweights. Four rounds. One champion 👑 First round’s results dropped today, each winner is determined by each week’s performance. No votes, no hype. Just the numbers. After four rounds, only one stock will remain.